Search Medical Condition
Please enter condition
Please choose location

Diabetes (Pediatric) Clinical Trials

A listing of Diabetes (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (26) clinical trials

Winthrop University Hospital Clinical Trials Center is conducting a clinical research study for participants (ages 10-17 years old), who have been diagnosed with type 2 diabetes. The purpose of this research study is to test the safety and effectiveness of an oral investigational drug to lower blood sugar in Pediatric ...

Phase

A study to evaluate the two new sensors performance in pediatric patients with insulin requiring diabetes

Phase N/A

To confirm the effect of treatment with meal-time faster-acting insulin aspart in terms of glycaemic control by comparing it to meal-time NovoRapid®, both in combination with insulin degludec using a non-inferiority approach in children and adolescents with type 1 diabetes.

Phase N/A

The purpose of this research study is to investigate whether the trial product is effective and safe in reducing/managing weight in children. Winthrop-University Hospital Clinical Trials Center is seeking study participants (ages 7-11 years old), who have not started puberty to take part in this clinical research study because he/she ...

Phase

The PEDALon clinical research study is testing an investigational medication for children with type 2 diabetes. Researchers are studying whether this medication may help children maintain blood sugar levels. If your child volunteers and qualifies, he or she will receive study-related medication and care – including diet and exercise counseling ...

Phase N/A

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

The patients are expected to participate in the study for approximately 6 to 8 weeks from Screening to final follow-up visit. Patients who completed 4 weeks of Afrezza treatment and have shown to be safe and well controlled with Afrezza + basal insulin will have the option to continue the ...

Phase

Versartis Long-Term Safety Study of Somavaratan

Protocol 13VR3 is a multi-center, open-label study assessing long-term somavaratan administration. It is open to subjects completing a somavaratan study in children with growth hormone deficiency (GHD), as well as up to 100 new treatment naïve subjects with GHD. All subjects will receive somavaratan 3.5 mg/kg twice monthly. The study ...

Phase

Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes

Scientific justification: Clinical and preclinical studies, together with supportive mechanistic data showing that Tregs are activated by much lower IL-2 concentration than effector T cells (Teffs), provide a strong rationale for studying efficacy of low dose IL2 to stop the autoimmune destruction of insulin-secreting beta cells in patient with recently ...

Phase